Metraipolis › archive › dc_e0ebef26ec4a

Boron Theranostic Nanoplatform Utilizing a GO@Carborane@Au Hybrid Framework for Targeted Delivery — Europe PMC PMID:41754930

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41754930
DOI
10.3390/pharmaceutics18020188
License (as archived)
solo-consultazione
Archived
2026-10-07T23:45:57.123Z
SHA-256 of the archived text
99754058301ffe5701ad67014fa9e3553a9624f32cecc59b069301d48643bf2c
Stable URL of this page
https://metraipolis.com/documento/dc_e0ebef26ec4a

How to cite

Boron Theranostic Nanoplatform Utilizing a GO@Carborane@Au Hybrid Framework for Targeted Delivery — Europe PMC PMID:41754930 — Europe PMC (en), https://europepmc.org/article/MED/41754930 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e0ebef26ec4a (Metraipolis archive dc_e0ebef26ec4a, sha256 99754058301ffe5701ad67014fa9e3553a9624f32cecc59b069301d48643bf2c)
BibTeX
@misc{dce0ebef26ec4a,
  title = {Boron Theranostic Nanoplatform Utilizing a GO@Carborane@Au Hybrid Framework for Targeted Delivery — Europe PMC PMID:41754930},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41754930},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e0ebef26ec4a; sha256 99754058301ffe5701ad67014fa9e3553a9624f32cecc59b069301d48643bf2c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41754930. Agents can read the archived copy with the MCP tool read_document.